Wang Renhe, Zhao Haijun, Zhang Yingyu, Zhu Hai, Su Qiuju, Qi Haiyan, Deng Jun, Xiao Chengcheng
Department of Traditional Chinese Medicine, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Department of Urology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Front Genet. 2021 Jan 11;11:616947. doi: 10.3389/fgene.2020.616947. eCollection 2020.
Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI) and has no effective treatment. Exploring the molecular mechanisms of renal IRI is critical for the prevention of AKI and its evolution to chronic kidney disease and end-stage renal disease. The aim of the present study was to determine the biological function and molecular mechanism of action of miR-92a-3p in tubular epithelial cell (TEC) pyroptosis. We investigated the relationship between nuclear factor-erythroid 2-related factor 1 (Nrf1) and TEC pyroptosis induced by ischemia-reperfusion and oxygen-glucose deprivation/reoxygenation (OGD/R) . MicroRNAs (miRNAs) are regulators of gene expression and play a role in the progression of renal IRI. Nrf1 was confirmed as a potential target for miRNA miR-92a-3p. In addition, the inhibition of miR-92a-3p alleviated oxidative stress and decreased the expression levels of NLRP3, caspase-1, GSDMD-N, IL-1β, and IL-18 and . Moreover, Zn-protoporphyrin-IX, an inhibitor of heme oxygenase-1, reduced the protective effect of Nrf1 overexpression on OGD/R-induced TEC oxidative stress and pyroptosis. The results of this study suggest that the inhibition of miR-92a-3p can alleviate TEC oxidative stress and pyroptosis by targeting Nrf1 in renal IRI.
肾缺血再灌注损伤(IRI)是急性肾损伤(AKI)的主要原因,且尚无有效治疗方法。探索肾IRI的分子机制对于预防AKI及其向慢性肾脏病和终末期肾病的进展至关重要。本研究的目的是确定miR-92a-3p在肾小管上皮细胞(TEC)焦亡中的生物学功能和分子作用机制。我们研究了核因子红细胞2相关因子1(Nrf1)与缺血再灌注和氧糖剥夺/复氧(OGD/R)诱导的TEC焦亡之间的关系。微小RNA(miRNA)是基因表达的调节因子,在肾IRI的进展中起作用。Nrf1被确认为miRNA miR-92a-3p的潜在靶点。此外,抑制miR-92a-3p可减轻氧化应激,并降低NLRP3、半胱天冬酶-1、GSDMD-N、白细胞介素-1β和白细胞介素-18的表达水平。此外,血红素加氧酶-1抑制剂锌原卟啉-IX降低了Nrf1过表达对OGD/R诱导的TEC氧化应激和焦亡的保护作用。本研究结果表明,在肾IRI中,抑制miR-92a-3p可通过靶向Nrf1减轻TEC氧化应激和焦亡。